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Summary
Background: Mammalian Diaphanous (mDia)-related
formins and the N-WASP-activated Arp2/3 complex ini-
tiate the assembly of filamentous actin. Dia-interacting
protein (DIP) binds via its amino-terminal SH3 domain
to the proline-rich formin homology 1 (FH1) domain of
mDia1 and mDia2 and to the N-WASp proline-rich
region.
Results: Here, we investigated an interaction between a
conserved leucine-rich region (LRR) in DIP and the mDia
FH2 domain that nucleates, processively elongates, and
bundles actin filaments. DIP binding to mDia2 was
regulated by the same Rho-GTPase-controlled autoinhi-
bitory mechanism modulating formin-mediated actin
assembly. DIP was previously shown to interact with
and stimulate N-WASp-dependent branched filament
assembly via Arp2/3. Despite direct binding to both
mDia1 and mDia2 FH2 domains, DIP LRR inhibited
only mDia2-dependent filament assembly and bundling
in vitro. DIP expression interfered with filopodia for-
mation, consistent with a role for mDia2 in assembly
of these structures. After filopodia retraction into the
cell body, DIP expression induced excessive nonapop-
totic membrane blebbing, a physiological process
involved in both cytokinesis and amoeboid cell move-
ment. DIP-induced blebbing was dependent on mDia2
but did not require the activities of either mDia1 or
Arp2/3.
Conclusions: These observations point to a pivotal
role for DIP in the control of nonbranched and branched
actin-filament assembly that is mediated by Diapha-
nous-related formins and activators of Arp2/3, respec-
tively. The ability of DIP to trigger blebbing also
suggests a role for mDia2 in the assembly of cortical
actin necessary for maintaining plasma-membrane
integrity.
Introduction
The Rho family GTPases regulate diverse cellular activ-
ities, including actin and microtubule dynamics, gene
transcription, cell cycle, and membrane trafficking.
*Correspondence: art.alberts@vai.orgRho proteins act as binary, nucleotide-dependent
switches that promote the formation of distinct actin
structures: RhoA, which promotes the formation of
stress fibers and focal adhesions; Rac, lamellipodia
and membrane ruffles; and Cdc42, filopodia or micro-
spikes [1]. Rho GTPase signaling is achieved by GTP-
dependent interactions with autoregulated effector
proteins including mammalian Diaphanous-related
formins (mDia1, mDia2, and mDia3) and neuronal
Wiscott-Aldrich syndrome protein (N-WASp) [2].
mDia protein-mediated actin-filament assembly is
controlled by intramolecular interactions mediated
by the Dia-inhibitory domain (DID) [3] and Dia-autoregu-
latory domain (DAD) [4] (Figure 1A). To activate mDia
proteins, activated GTPases bind to Armadillo-repeat
structures within the GTPase-binding domain (GBD)-
DID region and sterically interfere with DAD binding [5,
6]. The release of DAD relieves DID inhibition of the
formin homology 2 (FH2) domain, which is then free to
nucleate, processively elongate, and (in some cases)
bundle nonbranched actin filaments [7, 8]. Whereas
mDia proteins assemble actin by direct association
with the barbed ends of growing filaments, other
GTPase effector proteins, such as those of the WASp/
Scar family, indirectly promote actin assembly by stim-
ulating the Arp2/3 complex to bind to preexisting fila-
ments and nucleate branched filaments at their pointed
end [2].
The mDia and WASp protein families share several
binding partners, including Src, IRSp53, profilin, and
Dia-interacting protein (DIP) [9]. DIP is also known as
SPIN90, a binding partner for the adaptor Nck. Human
DIP is 91% identical to its murine homolog, WISH [10].
Through its amino-terminal SH3 domain, DIP binds to
the respective proline-rich regions of N-WASp, mDia1,
and mDia2 proteins [10, 11]. Upon binding to N-WASp,
DIP stimulates Arp2/3-mediated nucleation indepen-
dently of Cdc42 [10]; DIP was also shown to bind and
directly activate the Arp2/3 complex [12, 13].
Although these studies point to DIP as a positive reg-
ulator of N-WASp- and Arp2/3-mediated nucleation of
branched filaments, little is known about how DIP influ-
ences formin-mediated actin-filament assembly. DIP
also bears a polyproline-rich domain (PRD) recognized
by the N-WASp and Nck SH3 domains [10, 13] and a con-
served C-terminal leucine-rich region (LRR) [11]. The
LRR resides within a peptide isolated by a two-hybrid
screen with mDia2 as bait [11]. Until now, the LRR inter-
action with either mDia1 or mDia2 has been uncharac-
terized.
In this study, we examine the role of the DIP LRR inter-
action with mDia proteins and identify DIP and the LRR
as negative regulators of mDia2-mediated actin-fila-
ment assembly. DIP inhibition of mDia2 leads to dimin-
ished filopodia assembly and promotes nonapoptotic
membrane blebbing, indicating a novel role for formins
in the control of actin dynamics at the interface between
the cytoskeleton and plasma membrane.
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(A) Schematic of Dia-interacting protein and mDia. The line indicated with the asterisk (*) represents the mDia2:DIP interaction originally identified
by yeast two-hybrid screen; mDia also interacts with DIP through the mDia2 FH1 and DIP SH3 domains. Abbreviations are as follows: PRD,
proline-rich domain; LRR, leucine-rich domain; GBD, GTPase-binding domain; DID, Diaphanous-inhibitory domain; FH1, formin homology
domain-1; FH2, formin homology domain-2; and DAD, Dia-autoregulatory domain.
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DIP Binds the mDia2 FH2 Region In Vitro and in Cells
The DIP and DIP LRR (Figure 1A) interaction with the
mDia2 FH1-FH2 domains was identified previously via
two-hybrid screening. The interaction between endoge-
nous DIP and mDia2 was confirmed in HeLa cells by
coimmunoprecipitation (Figure 1B). We next confirmed
that ectopically expressed mDia and the DIP LRR inter-
act in cells by coimmunoprecipitation. HA-tagged
full-length (FL) DIP or DIP LRR was coexpressed in
HEK293T cells with epitope-tagged mDia2 or mDia1.
FL DIP and DIP LRR were associated with both mDia2
and mDia1 (Figures 1C and 1D, respectively).
The mDia2 FH1 domain also associated with FL DIP
(data not shown) but not with DIP LRR, consistent with
previous studies [11]. In vitro pulldown assays with a
glutathione-S-transferase (GST)-fusion of DIP LRR
demonstrated a direct interaction with the purified, re-
combinant FH2 domains of both mDia1 (Figure 1E) and
mDia2 (Figure 1F). This showed that the mDia FH2
domain was sufficient for binding to DIP LRR. The inter-
action between FL DIP and the isolated FH2 domains
was also confirmed (data not shown). Collectively, these
data validated DIP’s potential for the two following
modes of interaction with mDia1 or mDia2: mDia FH1
domains binding to the DIP SH3 domain or mDia FH2
domains interacting with the DIP LRR.
The DIP–mDia2 Interaction Can Be Controlled
by Cdc42
To validate a direct interaction between mDia2 and DIP,
a GST-fusion of FL DIP was incubated with recombinant
FL mDia2, mDia2 FH2-DAD, or mDia2 DAD. In contrast
to the immunoprecipitation results (Figures 1B and
1C), FL mDia2 did not bind DIP in vitro (Figure 1G; lane
4). This result led to the hypothesis that DIP binding to
the mDia2 FH2 domain was controlled by the autoregu-
latory mechanism maintained by the mDia DID and DAD
domains (Figure 1A) [14].
The mDia autoregulatory mechanism can be un-
latched by the addition of DAD peptide [4, 15]. The addi-
tion of 0.1 mM DAD induced GST-DIP to bind FL mDia2
(Figure 1G, lane 5). The isolated FH2-DAD region also
constitutively bound DIP (lane 7), whereas the DAD
alone did not (Figure 1G, lane 6).
mDia2 interacts with multiple Rho GTPases in vitro,
including RhoA, Cdc42, and Rif1 [16–18]. Therefore,
we tested whether an activated GTPase induced
mDia2–DIP binding. Addition of Cdc42 G12V (0.1–
0.5 mM) induced a proportionate increase in mDia2 bind-
ing to DIP (Figure 1H). Interestingly, GST-DIP LRR binds
to FL mDia2 in the absence of GTPase or DAD, sug-
gesting a constitutive association (Figure S1 in theSupplemental Data available online). Hence, autoregu-
lated mDia2 may be more accessible to DIP LRR than
to FL DIP. Indeed, intramolecular interactions between
the SH3 and PRD domains may restrict DIP’s binding
to other proteins, such as mDia or Grb2 [11]. DIP–
mDia2 binding represents the first known inducible
interaction of the GTPase-regulated formin proteins.
Although these observations indicate that the mDia2–
DIP interaction is regulated by activated Cdc42, the
interaction may also be regulated by other GTPases or
mDia- or DIP-binding proteins.
DIP Specifically Inhibits mDia2-Mediated
Actin-Filament Assembly
The murine DIP homolog, WISH, binds the nucleation
promoting factor N-WASP, and both DIP and WISH di-
rectly activate Arp2/3 [12]. We examined the effect of
DIP on the ability of mDia2 to assemble actin filaments.
As shown previously [7], mDia2 potently accelerates ac-
tin polymerization (Figure 2A). Incubating mDia2 with
DIP prior to mixing with actin monomers reduced
mDia2 nucleation activity in a dose-dependent manner,
whereas DIP alone did not alter actin polymerization. In-
terestingly, mDia1-mediated nucleation was unaffected
by incubation with DIP (Figure 2B). Therefore, although
DIP binds both mDia1 and mDia2 [11], DIP acts only as
a negative regulator of mDia2-mediated actin assembly
in vitro.
DIP Disrupts mDia2-Mediated Bundling
of Actin Filaments
A subset of formins—including mDia2 and a yeast
homolog, Bnr1p—bundle actin filaments, whereas their
closely related counterparts mDia1 and Bni1p do not
[8, 19]. DIP was tested for an effect on mDia2-mediated
filament bundling by low-speed pelleting assays. At low
speed, only crosslinked networks of filaments pellet,
whereas single filaments remain in the supernatant.
The mDia2 FH2 domain caused phalloidin-stabilized
actin filaments to pellet in a concentration-dependent
manner (Figure 2C). Preincubating mDia2 FH2 domain
(400 nM; see Figure 2C, lane 4) with FL DIP reduced
the amount of pelleted actin in a concentration-
dependent manner (Figure 2D). FL DIP neither pelleted
on its own nor caused actin to pellet. Recombinant
mDia2 protein containing both the FH1 and FH2
domains was also tested (data not shown); FL DIP
inhibited FH1-FH2-mediated bundling, similar to the
FH2 domain alone. Thus, DIP acts as a negative regula-
tor of mDia2-associated actin-assembly activities.
DIP Suppression Enhances Filopodia Formation
mDia2 has a role in filopodia assembly [14, 17, 18]. To
determine whether DIP affects mDia2 function in cells,(B) HeLa cell lysates were immunoprecipitated and immunoblotted with mDia2 or DIP antibodies.
(C and D) HA-tagged DIP or HA-DIP LRR was coexpressed with Myc-tagged mDia2 (C) or FLAG-tagged mDia1 (D) in HEK293T cells, and anti-Myc
(or FLAG) immunoprecipitations were performed. Blots were probed with anti-HA and anti-Myc or FLAG antibodies.
(E and F) In vitro binding assays were performed with 0.4 mM recombinant GST or GST-fused DIP LRR bound to resin and increasing amounts
(0.1–10.0 mM) of mDia1 or mDia2 FH2 protein. Recombinant mDia FH2 domain pulled down with GST-DIP LRR was visualized by Coomassie
staining.
(G and H) In vitro binding assays were performed with 0.5 mM recombinant GST-fused DIP bound to resin, with 0.1 mM FL mDia2 (aa 1–1171),
mDia2 FH2-DAD (aa 609–1171), DAD (aa 1039–1171) or increasing amounts (0.1–0.5 mM) of activated Cdc42 (G12V). Left panels show one-tenth
protein input into the assay; right panels show recombinant formin pulled down with GST-DIP resin in the presence or absence of DAD (G) or
Cdc42 G12V (H). Proteins were blotted with mDia2 antibodies.
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mDia2 Actin Nucleation and Filament Bun-
dling
(A and B) Pyrene-actin polymerization assays
containing 4 mM monomeric actin and indi-
cated concentrations of formin and DIP con-
structs. (A) shows 20 nM mDia2 FH2 in the
presence of increasing FL DIP. (B) shows
20 nM mDia1 FH2 in the presence of 4 mM DIP.
(C and D) Low-speed pelleting assays with
2 mM phalloidin-stabilized actin filaments
and mDia2 FH2 domain. Binding and pelleting
were conducted in polymerization buffer, and
samples separated by SDS-PAGE before
staining with Coomassie blue. (C) shows that
actin was incubated with increasing concen-
trations of mDia2. Lanes are described as
follows: lane 1, 2 mM actin alone; lanes 2–6,
2 mM actin plus 100, 200, 400, 600, and
800 nM mDia2, respectively. (D) shows that
400 nM mDia2 was incubated with increasing
concentrations of DIP-Full. Lanes 1–6 contain
400 nM mDia2 plus 0.25, 0.5, 1, 2, 4, and 8 mM
DIP-C (LRR), respectively, plus 2 mM actin.
The asterisk marks a breakdown product
that could not be purified away from FL DIP.we suppressed DIP expression by siRNA (Figure S2).
HeLa cells expressing DIP siRNA and stimulated with
EGF exhibited a striking morphology: Copious filopodia
emanated from the cell membrane (Figure 3A and Movie
S1). LacZ-siRNA-expressing cells did not differ morpho-
logically from uninjected counterparts (Figure 3A and
Movie S1). Fixed DIP-siRNA-expressing cells showed
a 50% increase in EGF-induced filopodia when DIP
expression was abrogated (Figures 3B and 3C). These
data suggest that when DIP is suppressed, mDia2 activ-
ity is enhanced.
DIP Interferes with Filopodia Assembly and Triggers
Nonapoptotic Membrane Blebbing
We coexpressed DIP with an activator of mDia2 to test
whether DIP negatively affects filopodia formation. Cells
expressing either CFP-Cdc42-G12V or EGFP-DIP alone
or in combination were imaged by time-lapse differential
interference contrast (DIC) microscopy to track filopodia
formation. Although FL DIP did not affect cell morphol-
ogy relative to noninjected cells (Figure 4A), activated
Cdc42 induced filopodia formation (Figure 4B). In con-
trast, coexpression of activated Cdc42 with FL DIP
caused cells to retract filopodia, round, and then bleb
(Figure 4C and Movie S2). Dynamic blebbing occurred
in cells coinjected with Cdc42 and DIP in both the
presence and absence of EGF (Figure 4C and data not
shown). Therefore, DIP not only inhibited filopodia
assembly triggered by activated Cdc42 but also af-
fected the machinery that controls membrane integrity.
mDia2 acts as an effector protein for multiple
GTPases, including RhoA [9]; RhoA has been shown to
localize to blebs [20]. Therefore, cells expressing RhoAG14V were compared to cells expressing RhoA with FL
DIP. Cells expressing CFP-RhoA-G14V were spread
out (Figure 4D) with organized stress fibers, consistent
with the known effects of activated RhoA. Upon coex-
pression of RhoA-G14V with FL DIP, cells rounded and
blebbed (Figure 4E). The result is consistent with the
concept that to bind DIP, mDia2 must be activated by
a GTPase (see Figure 1). EGFP-fused DIP LRR expres-
sion was sufficient for inducing blebbing (Figure 4F).
This result was not surprising given that DIP LRR protein
constitutively binds to FL mDia2 in binding assays (data
not shown). Purified, recombinant DIP LRR protein
microinjected into cells was equally capable of inducing
filopodia retraction and blebbing within 10 min (Fig-
ure 4F, inset).
Nonapoptotic membrane blebbing is a conserved,
physiological process, and it is involved in diverse pro-
cesses such as cell division, cell spreading, neuronal
cell migration, and apoptosis [21–24]. Bleb initiation
involves local changes in the contractility of the cortical
actinomyosin cytoskeleton by modifying the phosphor-
ylation of myosin II regulatory light chain (MRLC) via
myosin light-chain kinase or Rho kinase (ROCK) [25,
26]. Several actin-binding proteins are recruited to blebs
in constitutively blebbing cells, including ezrin and
moesin [20], indicating that the actin architecture plays
a fundamental role in the control of the blebbing
mechanism.
Drugs disrupting F-actin or actinomyosin contraction
alter blebbing dynamics in constitutively blebbing cell
lines [20, 25, 27]. For determining the need for actino-
myosin contraction, cells injected with recombinant
DIP LRR were treated with blebbistatin, a myosin II
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(A) HeLa cells injected with plasmid encoding both EGFP and siRNA against human DIP or lacZ. After 24 hr, cells were stimulated with 2 mM EGF
and imaged by live-cell confocal microscopy.
(B) HeLa cells were injected with plasmid encoding both EGFP and siRNA against human DIP or lacZ. After 24 hr, cells were stimulated with 2 mM
EGF, fixed after 5 min, and stained with phalloidin. Insets depict EGFP expression in injected cells.
(C) Quantitation of filopodia where 20–40 injected cells were visualized by time-lapse microscopy and scored for blebbing from three indepen-
dent experiments; error bars represent the mean 6 sample SD.ATPase inhibitor. HeLa cells injected with 0.1 mM DIP
LRR protein were imaged for 30 min (Figures S3A and
S3C and Movie S3). Cells were then treated with 10 mM
blebbistatin and imaged for an additional 30 min. Bleb-
bistatin blocked DIP-LRR-induced blebbing (Figures
S3B and S3D and Movie S3), while DMSO-treated cells
continued to bleb (Figure S3E). Similar results were ob-
tained with a Rho-kinase inhibitor, Y-27632 (data not
shown), indicating that DIP-LRR-mediated blebbing
involves Rho kinase-controlled myosin II-dependent
contractility.
We next assessed whether DIP expression induces
RhoA activation and phosphorylation of MRLC through
ROCK I. HEK293T cells were transfected with GFP-
fused DIP or DIP LRR, and cell lysates were subjected
to pulldown assays with the GST-Rhotekin Rho-binding
domain (RBD) and immunoblotted for RhoA. Neither FL
DIP nor DIP LRR activated RhoA when compared with
control GFP-transfected lysates (Figure S3G). Further-
more, whereas activated ROCK I Opa G1114 enhanced
MRLC phosphorylation relative to controls, MRLC phos-
phorylation was unchanged in FL DIP- or DIP-LRR-
transfected cells. These data show that DIP is not
a global activator of MRLC phosphorylation and istherefore not inducing blebbing indirectly through
ROCK. However, actomyosin contraction is required
for DIP-induced blebbing because both blebbistatin
and the Rho-kinase inhibitor (Y-27632) reversibly inhibit
blebbing in DIP-LRR-injected cells (Figure S3 and data
not shown).
mDia2-Binding-Deficient Variants of DIP LRR
Have Impaired Blebbing Activity
Primary amino acid sequence alignments revealed that
the DIP LRR is highly conserved (Figure 5A); DIP homo-
logs were identified in budding and fission yeast,
insects, and amphibia through database searches. The
alignments were used for identifying residues within
the LRR potentially mediating the DIP–mDia2 interac-
tion. Several conserved residues (indicated by arrow-
heads in Figure 5A) were converted to alanine, and
plasmids expressing the DIP LRR variants as CFP fusion
proteins were cotransfected into HEK293T cells with
mDia2; then, coimmunoprecipitations were performed.
Although the N555 residue was not perfectly conserved,
DIP LRR N555A binding to mDia2 was impaired, and
the double-aspartate-substituted D628/634A variant
had no appreciable binding defect (Figure 5B).
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(A–F) HeLa cells were injected with plasmids encoding CFP-Cdc42 G12V, CFP-RhoA G14V (false-colored green) along with EGFP DIP or EGFP
DIP LRR as indicated. Four hours after injection, cells were stimulated with 2 mM EGF for 5 min, and live-cell confocal imaging was performed for
10–20 min. The inset of (F) shows HeLa cells injected with 0.1 mM recombinant DIP LRR protein.The N555A and D628/634A variants were purified as
recombinant proteins (Figure 5D and data not shown)
and tested in GST pulldowns for mDia2 binding (Fig-
ure 5C). Consistent with the coimmunoprecipitation,
the N555A DIP variant bound poorly to the FH1-FH2 re-
gion of mDia2, whereas D628/634A LRR binding was
comparable to the binding of intact DIP LRR. Quantifica-
tion of DIP LRR N555A binding to the mDia2 FH2 domainshowed that binding was compromised when compared
with DIP LRR (Figure 5E). The DIP LRR or N555A LRR re-
combinant proteins (0.1 mM each) were then microin-
jected into HeLa cells; DIP LRR induced blebbing within
5–20 min (Figure 5F), but N555A LRR induced blebbing
in fewer cells. Collectively, these studies indicated that
DIP-induced blebbing depends upon its ability to bind
to the mDia2 FH2 domain.
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(A) Schematics illustrating the DIP leucine-rich region across diverse species. Sequence alignments were generated by clustalW analysis; gaps
are shown in white. Residues matching the consensus sequence are shown in dark blue. A nonconsensus residue with a positive Blosum62
score is shown in light blue. Arrows indicate residues targeted for alanine substitution. Genbank accession numbers for DIP and its homologs
are as follows: H. sapiens DIP, BAB63205; M. musculus WISH, AAF36503; X. laevis, AAH73218; D. melanogaster, NP_996372; S. pombe,
SPBC24C6; and S. cerevisiae Ldb17p, YDL146W.
(B) CFP-tagged wild-type or alanine-substituted DIP LRR were coexpressed with Myc-tagged mDia2 in HEK293 cells, and anti-Myc immunopre-
cipitations were performed. Blots were probed with CFP and Myc antibodies.
(C and D) In vitro binding assays were performed with 0.4 mM recombinant GST-fused wild-type or alanine-substituted DIP LRR bound to resin
(shown in [D]), with 0.1 mM mDia2 FH2-DAD. Proteins were blotted with mDia2 antibodies.
(E) In vitro binding assays were performed with 0.4 mM recombinant GST, GST-fused DIP LRR, or DIP LRR N555A bound to resin with 0.1–10.0 mM
mDia2 FH2 protein. Recombinant mDia2 FH2 domain pulled down with GST-DIP LRR were visualized by Coomassie staining and quantitated by
densitometry.
(F) HeLa cells were injected with recombinant either DIP LRR wild-type or LRR N555A protein and fluorescent dextran, with imaging performed
for 10–20 min. Error bars represent the mean percentage of cells blebbing 6 the SD.
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and Arp2/3
DIP-mediated blebbing could be due to effects on
mDia1, which binds DIP through its FH1 domain [11].
Alternatively, DIP could directly activate Arp2/3 or in-
appropriately activate Arp2/3 through N-WASp [10, 12,
13, 28]. Initially, we tested whether mDia1 was required
for DIP-induced blebbing. DIP LRR and N555A LRR
recombinant proteins were microinjected into 2D6 cells
[17]. These mDia1 knockout cells express elevated
mDia2 and generate many filopodia. Microinjected cells
were fixed and stained with fluorescent phalloidin for
visualization of the F-actin architecture (Figure 6A).
Relative to cells injected with marker alone (data not
shown) or N555A LRR, DIP-LRR-injected cells immedi-
ately lost their microspikes (Figure 6B). Within 10–
20 min, cells began to bleb (Figure 6C). Therefore,
although DIP binds to mDia1, it does not require this
interaction to drive membrane blebbing.
Recently, Arp 2/3 was demonstrated to bind the DIP
LRR [12]. To address whether the Arp2/3 complex [29]
is involved in DIP-mediated blebbing, we injected
mouse embryonic fibroblasts (MEFs) expressing siRNA
targeting the Arp3 subunit [30] with recombinant DIP
or DIP LRR (Figure 7; Movie S4). Despite Arp3 depletion,
cells injected with DIP LRR blebbed profusely (Fig-
ure 7A), unlike those injected with marker alone
(Figure 7B). MEFs expressing control siRNA blebbed
upon introduction of DIP LRR (Figure 7C). Furthermore,
the numbers of blebbing cells after injection were nearly
identical in Arp3 knockdown and control parental MEFs
(Figure 7D). Collectively, these data suggest that DIP-
mediated bleb induction occurred independently of
N-WASp/Arp2/3. This result is consistent with ob-
servations made in Arp2/3-defective strains of Dictyos-
telium, which bleb in response to chemoattractant
despite the disruption of Arp2/3-mediated actin poly-
merization [31].
Requirement of mDia2 in DIP-Mediated Blebbing
The assembly of the actin cortex is necessary for dy-
namic membrane blebbing and requires actin polymeri-
zation. However, the identity of the actin nucleator(s)
critical for perpetuating the blebbing phenotype remains
elusive; not Arp2/3, VASP, or mDia1 localize to blebs or
are required for blebbing [20]. We assessed the require-
ment for mDia2 in DIP-mediated blebbing. siRNA
directed against human mDia2 was stably expressed
in HeLa cells (Figure S4). mDia2 knockdown cells ruffled
extensively (Figure 8B). Control cells injected with re-
combinant DIP LRR protein rounded and blebbed (Fig-
ure 8A; 21/26 cells), whereas mDia2 knockdown cells
microinjected with recombinant DIP LRR protein failed
to bleb (Figure 8C; 0/21 cells). NIH 3T3 cells, which
have little or no detectable mDia2 [11], were also refrac-
tory to the effect of microinjected with DIP LRR (Fig-
ure 8D; 2/28 cells). However, NIH 3T3 cells expressing
a truncated, constitutively active variant of Rho-kinase
I (ROCK I-G1114 Opa [25]) (Figure 8E; 23/25 cells)
blebbed profusely, indicating that the blebbing machin-
ery downstream of RhoA/ROCK is intact. Finally,
HeLa cells expressing dominant-negative mDia (mDia
FH2DN) blebbed profusely (Figure 8F; 17/23 cells).Collectively, these data indicate that DIP-induced bleb-
bing depends on mDia2 function.
Discussion
In this study, we uncovered DIP as a negative regulator
of mDia2. DIP specifically inhibited mDia2-mediated
actin nucleation and bundling activity in vitro, despite
its ability to bind both mDia1 and mDia2. DIP disrupted
the ability of mDia2 to assemble filopodia and induced
exaggerated nonapoptotic membrane blebbing in cells.
This phenomenon points to a role for mDia2 in the
assembly of F-actin at the cell cortex, which contributes
to plasma-membrane morphology. The interaction
between DIP and mDia2 is tightly controlled by the
mDia2 autoregulatory mechanism that also governs
formin-mediated actin nucleation and filament elon-
gation. Thus, DIP-mediated inhibition of mDia2 pro-
vides an additional regulatory mechanism complement-
ing the GTPase-controlled intramolecular DID-DAD
switch [3].
DIP Binds and Inhibits mDia2-Mediated Actin
Nucleation and Filament Bundling
Our results demonstrate that DIP binds to mDia proteins
through multiple protein–protein interaction domains.
The formin FH1 and FH2 domains bind to the DIP SH3
and leucine-rich C terminus, respectively. Although the
binding results are consistent with previously published
results [11], in our hands the FL DIP interaction with
mDia2 is more robust than the association with mDia1
in cells. The dissimilarities may be significant and war-
rant further investigation. mDia1 and mDia2 FH2 do-
mains’ structural differences, which allow the latter to
bind and bundle actin filaments, may account for the dif-
ferences in sensitivity to DIP. The in vitro experiments,
however, do not take into account possible posttransla-
tional modifications, of either binding partner, that may
affect the mDia–DIP interaction within cells.
We demonstrate that the DIP–mDia2 interaction is
tightly controlled by the GTPase-governed autoinhibi-
tory mechanism. mDia2 autoinhibition can be relieved
via introduction of DAD or activated Cdc42, which trig-
gers binding to DIP. Consistent with this model, expres-
sion of DIP with either activated Cdc42 or activated
RhoA interfered with filopodia assembled by mDia2,
but expression of FL DIP had no discernable effect. To-
gether, the data suggest that DIP inhibition of mDia2
depends on the formin first becoming activated. In other
words, DIP binding to the FH2 domain is permissive, and
the interaction is sequential.
DIP’s failure to affect mDia1 also raises the question of
what purpose the interaction serves in cells. One possi-
bility is that DIP brings mDia1 and its filament nucleation
and elongation activities into proximity with N-WASp or
activated Arp2/3 for facilitating cooperation between
the machineries driving branched and nonbranched
filament assembly [32]. Thus, DIP may act as a pivot
between branched and nonbranched actin networks.
Likewise, production of dendritic networks would
benefit from mDia2 inhibition, which tends to drive filo-
podia assembly [17, 18]; juxtaposition of mDia1 with
the nucleation-promoting factor WASp in cells would
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(A) 2D6 cells were injected with 0.1 mM purified, recombinant DIP LRR or DIP LRR N555A and Oregon green dextran. Cells were stimulated with
2 mM EGF for 5 min, and cells imaged through 10 min. Cells were fixed at indicated time points and stained with fluorescent phalloidin.
(B) Cells displaying filopodia (filopodia positive); error bars represent the percentage of injected cells with filopodia 6 the SEM. Filopodia were
quantitated from cells documented in (A) at indicated time points.
(C) Blebbing cells were quantitated from cells documented in (A). Error bars represent the percentage of cells blebbing 6 the SD.allow activated Arp2/3 to utilize newly ‘‘minted’’ fila-
ments nucleated by the formin for side branching [33].
In support of this model, T cells isolated from mDia1
knockout mice fail to ruffle in response to adhesion to
stimulatory substrates (K.M.E., unpublished data).DIP and mDia2 in Cortical Actin-Cytoskeleton
Assembly
Dynamic blebbing involves multiple events at the
plasma membrane; blebbing is indicative of the integrity
of the cell cortex and is an effective readout of cortical
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588Figure 7. DIP-Mediated Membrane Blebbing
Does Not Require Arp2/3
(A–C) MEFs expressing siRNA directed
against Arp3 (A and B) or control siRNA (C)
were injected with 0.1 mM recombinant DIP
LRR or DIP LRR N555A along with Texas-
red-dextran marker or marker alone; injected
cells were imaged for 10 min by live-cell con-
focal microscopy.
(D) Blebbing cells were quantitated from cells
(A–C); bars represent the mean percentage of
blebbing cells 6 SD.tension [34]. Paluch and colleagues [35] postulated that
breaks in the actin cortex allow cytoplasm, driven by hy-
drostatic pressure generated by actomyosin contrac-
tion, to exude blebs. Actin polymerization directed into
the bleb then participates in retraction of all or part of
the bleb. Aspects of this model have been demonstrated
in live cells by the visualization of F-actin assembly into
nascent blebs [20, 27]. F-actin is localized to the base of
expanded blebs, yet not within the bleb itself. Here, we
propose a role for mDia2 in maintaining the cortical actin
cytoskeleton. We postulate that mDia2 mediates the
elongation of F-actin into blebs and failure caused by
DIP LRR or DIP overexpression favors the exaggerated
bleb formation observed. This suggests an analogous
role for mDia2 in blebbing and maintaining the cell acto-
myosin cortex to that described in the assembly of F-ac-
tin within filopodia [14, 17].
A role for formins in bleb retraction was suggested, yet
mDia1 failed to localize to the bleb [20]. RhoA is localized
within the retracting bleb [16] and may activate mDia2
and promote actin-filament elongation necessary for
bleb retraction. Yet, the interaction between DIP and
the mDia2 FH2 domain inhibits filament elongation.
This paradox may be explained in that the DIP–mDia2 in-
teraction is tightly regulated by the GTPase-dependent
autoregulatory mechanism. When deregulated mDia2 in-
teracts with DIP, bleb retraction may be disrupted be-
cause of inhibition of filament elongation (visualized
through exaggerated blebs). Presumably, all cellular
mDia2 does not interact with DIP and thus activated
mDia2 not bound to DIP could nucleate and elongate fil-
aments that mediate bleb retraction. Furthermore, it is
unknown whether the DIP–mDia2 interaction is revers-
ible or how it is regulated (e.g., by phosphorylation or
cellular localization). The regulation of this interaction
requires further investigation.
Our results point to a role for mDia2 in maintenance of
the cortical actin cytoskeleton; DIP affects this activity in
a negative way, leading to blebbing. Knockdown orsimple nonexpression of mDia2 is not sufficient for in-
ducing blebbing. One potential explanation is that DIP
bound to mDia2 forms a complex that is more than sim-
ply inactive; it is also possible the DIP LRR-mDia2 com-
plex gains an ‘‘interfering’’ function that allows it to neg-
atively affect existing F-actin structures and induce or
exaggerate blebbing. DIP may also affect the activities
of its other binding partners. In addition to mDia2, the
DIP LRR interacts with a host of other proteins including
mDia1, FHOD (weak interaction) [36], and Arp2/3 [12].
Neither mDia1 nor Arp 2/3 localizes to the bleb [20],
nor does the loss of their expression affect DIP-LRR-
mediated blebbing. Therefore, in the absence of
mDia2, DIP LRR might interact with one or more of these
proteins and maintain the cortex. DIP may act as a bridge
between multiple types of actin nucleators and thus
integrate multiple GTPase (in)dependent signaling
pathways that affect actin remodeling.
We show that the DIP blebbing mechanism requires
myosin contractility, presumably through localized
ROCK I-mediated MRLC phosphorylation. However,
DIP (or DIP LRR) overexpression enhanced neither
global RhoA activation nor MRLC phosphorylation,
despite the recent localization of RhoA in the bleb mem-
brane [20]. Blebs induced via DIP are dynamic, suggest-
ing that local changes in the membrane proximal envi-
ronment (e.g., actin polymerization or bundling) and
RhoA activation and MRLC phosphorylation are likely
to mediate such changes [37]. Recently, Charras et al.
demonstrated localized effects of myosin-II-inhibiting
drugs on constitutively blebbing cells, and this suggests
that the actomyosin cortex acts locally to promote bleb-
bing [27]. Experiments exploring this hypothesis are
currently underway.
Other Roles for DIP in Signaling to the Cytoskeleton
The introduction of DIP LRR both decreased stress-fiber
formation and induced blebbing, which potentially
enhances cell motility. Indeed, suppression of DIP
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(A–C) HeLa cells were injected with plasmids encoding both EGFP and siRNA against mDia2 (B and C). At 24 hr, cells were (re)injected with 0.1 mM
recombinant DIP LRR and Texas-red (TR)-dextran marker, and cells were imaged by confocal microscopy.
(D and E) NIH 3T3 cells were injected with recombinant DIP LRR (D) or plasmid encoding ROCK I (G1114 Opa) with fluorescent Oregon green (OG)
dextran and imaged by confocal microscopy either immediately (D) or 4 hr (E) after injection.
(F) HeLa cells were injected with an EYFP-fused mDia FH2DN and imaged by confocal microscopy 4 hr after injection.expression [38] inhibits directed cell migration, suggest-
ing that DIP functions in cell motility. Therefore, a role for
DIP-mediated blebbing may be ascribed for promoting
amoeboid-like cancer-cell migration, such as that pro-
posed by Sahai and Marshall [26]. Together, these com-
bined activities for DIP point to a physiological role incell movement, which in some cases is dependent
upon blebbing. Blebbing was associated with motility
in fast-moving amoeboid cells [39]. Melanoma cells
were shown to oscillate between a bleb and an actin nu-
cleation and polymerization mode (via RhoA and ROCK
signaling) to facilitate cell motility [26]. Hence, blebbing
Current Biology
590induction via DIP may ultimately promote cancer-cell
metastasis.
Experimental Procedures
Cell Culture, Microinjection, Transfection, and Time-Lapse
Image Acquisition
HEK293T and HeLa cells were maintained in DMEM containing 10%
(v/v) FBS. 2D6 mDia1 null cells were derived as described [17] and
were maintained in DMEM containing 10% (v/v) FBS. Arp3 knock-
down (kd) and control pMSCV-expressing MEFs [30] (a kind gift
from Dr. David J. Kwiatkowski) were maintained in DMEM containing
10% (v/v) FBS, 10 mM HEPES, 1 mM MEM nonessential amino
acids, 100 units/ml penicillin, and 100 mg/ml streptomycin.
Cell lines for microinjection were changed to medium containing
0.1% (v/v) FBS 24 hr prior to all microinjections. HeLa and 2D6 cells
were plated on glass coverslips as described [17]. HeLa, 2D6, and
Arp3 knockdown MEFs were plated onto glass-bottom dishes (Mat-
Tek) and incubated for 14 hr in 0.1% DMEM for live-cell time-lapse
imaging or immunofluorescence. Cell microinjection and immuno-
fluorescence were performed as previously described [17, 40].
Purified protein was coinjected with Oregon green or Texas red
dextran (1 mg/ml) for identifying injected cells.
Time-lapse imaging was acquired with a Zeiss Axiovert 100M (633
objective) fitted with an environmental chamber that maintained
cells at 37C and in a 10% CO2-containing atmosphere. Images
were acquired at 10 s intervals with a Zeiss Axiocam controlled by
the Improvision software. Live-cell confocal imaging was performed
with a Zeiss LSM 510 META confocal laser-scanning microscope
with a 25 mW krypton-argon (488, 514, and 568 nm) and HeNe
(633 nm) and a Ti-sapphire pulse laser. An environmental chamber
maintained cells at 37C and in a 10% CO2-containing atmosphere.
A 0.5 mm slice was acquired at 5 s intervals for 20 min.
Transfection of HEK293T or HeLa cells was performed with
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
specifications. Cell lysates were prepared in lysis buffer (20 mM
Tris-HCl [pH 7.5], 100 mM NaCl, 1% NP40, and 10% glycerol)
containing 0.1 M sodium vanadate, 0.1 M aprotinin, 0.1 M pepstatin,
0.1 M leupeptin, 0.1 M dithiothreitol, and 0.1 M PMSF, and immuno-
precipitations were performed as described [40].
Recombinant Proteins, In Vitro Binding Assays
and Pyrene-Actin-Nucleation Assay
Recombinant proteins were prepared and purified as described by
Li and Higgs [15]. Binding assays were carried out by incubation
of 0.1 mM mDia2 (aa 1–1171), 0.1 mM mDia2 FH2-DAD (aa 609–
1171), 0.1 mM DAD (aa 1039–1171) or 0.1, 0.25, or 0.5 mM Cdc42
G12V with 0.5 mM DIP-GST fusion bound to glutathione beads in
TNM buffer (25 nM Tris [pH 7.2], 100 mM NaCl, and 10 mM MgCl2)
plus protease inhibitors (1 mM PMSF and 1 mM DTT) for 5 hr at
4C. Beads were washed thrice in TMN buffer adjusted with 0.1%
NP40 and NaCl to 0.15 M.
Pyrene actin nucleation and actin-bundling assays were per-
formed exactly as described by Li and Higgs [15]; recombinant
mDia1 and mDia2 FH2 domains with FL DIP proteins were used.
Intracellular Flow Cytometry
Cells (23 105) were fixed with Fix and Perm Cell Permeabilization Kit
(Caltag Laboratories) according to the manufacturer’s protocol.
Fluorescence was detected with a FACSCalibur flow cytometer
(Becton Dickenson).
Rho-Pulldown Assays
The Rhotekin Rho-binding domain was from Upstate (Millipore),
and the assay performed according to the manufacturer’s specifica-
tions. RBD bead loading was assessed by staining of the membrane
with Ponceau S (Sigma). Western blots were performed with RhoA
antibodies (Santa Cruz).
Antibodies and Plasmids
HA and Myc monoclonal antibodies were from VARI Monoclonal
Antibody Core Facility. Myc polyclonal antibodies were from Santa
Cruz Biotechnology. GFP/YFP/CFP antibody was from AbCam.
DIP rabbit polyclonal antibodies were generated against a C-terminal peptide of murine DIP (aa 587–608). GST antibodies were
from Cell Signaling. FLAG antibody was from Chemicon. Texas red
phalloidin and Oregon green and Texas red dextran were from
Molecular Probes.
EFm (Myc-tagged) mDia2, FLAG-tagged mDia1, and EGFP mDia1
FH1 domain were previously described [4, 40]. DIP FL and DIP LRR
were as described [11] and subcloned into pECFP vectors (Clon-
tech) [17]. DIP siRNA sequences were as previously published
[38]. mDia2 siRNA sequences were kindly provided by Dr. Shingo
Yasuda. Oligos were subcloned into pSuppressor Neo-GFP siRNA
vectors (a kind gift from Matt VanBrocklin).
Supplemental Data
Supplemental Data include four figures and four movies and are
available with this article online at http://www.current-biology.com/
cgi/content/full/17/7/579/DC1/.
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